Log in to save to my catalogue

Recent Research Progress of RGD Peptide–Modified Nanodrug Delivery Systems in Tumor Therapy

Recent Research Progress of RGD Peptide–Modified Nanodrug Delivery Systems in Tumor Therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2814208703

Recent Research Progress of RGD Peptide–Modified Nanodrug Delivery Systems in Tumor Therapy

About this item

Full title

Recent Research Progress of RGD Peptide–Modified Nanodrug Delivery Systems in Tumor Therapy

Publisher

Dordrecht: Springer Netherlands

Journal title

International journal of peptide research and therapeutics, 2023-05, Vol.29 (4), p.53, Article 53

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

There have been great advancements in targeted nanodrug delivery systems for tumor therapy. Liposomes, polymeric nanoparticles, and inorganic nanoparticles are commonly employed as nanocarriers for drug delivery, and it has been found that arginine glycine aspartic acid (RGD) peptides and their derivatives can be used as ligands of integrin recepto...

Alternative Titles

Full title

Recent Research Progress of RGD Peptide–Modified Nanodrug Delivery Systems in Tumor Therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2814208703

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2814208703

Other Identifiers

ISSN

1573-3904,1573-3149

E-ISSN

1573-3904

DOI

10.1007/s10989-023-10523-4

How to access this item